The Sentinel Project: An update on the prevalence of antimicrobial resistance in community-acquired respiratory Streptococcus pneumoniae and Haemophilus spp. in Italy

International Journal of Antimicrobial Agents

Volumn 26, Issue 1, 2005, Pages 8-12

  Marchese, A ^a   Ardito, F ^c   Fadda, G ^c   Fontana, R ^b   Lo Cascio, G ^b   Nicoletti, G ^d   Speciale, A M ^d   Schito, G C ^a  

^a UNIVERSITY OF GENOA   (Italy)

^b UNIVERSITY OF VERONA   (Italy)

^c CATHOLIC UNIVERSITY   (Italy)

^d UNIVERSITY OF CATANIA   (Italy)

Author keywords

Antibiotic resistance; Epidemiology; Pneumococci; Respiratory pathogens; Surveillance

Indexed keywords

AMOXICILLIN; AMPICILLIN; AZITHROMYCIN; BETA LACTAMASE; CEFACLOR; CEFIXIME; CEFTRIAXONE; CEPHALOSPORIN; CHLORAMPHENICOL; CIPROFLOXACIN; CLARITHROMYCIN; CLAVULANIC ACID; COTRIMOXAZOLE; ERYTHROMYCIN; LEVOFLOXACIN; MACROLIDE; PENICILLIN G; QUINOLINE DERIVED ANTIINFECTIVE AGENT; TETRACYCLINE;

ANTIBIOTIC RESISTANCE; ANTIBIOTIC SENSITIVITY; ARTICLE; COMMUNITY ACQUIRED PNEUMONIA; DRUG POTENCY; HAEMOPHILUS; HUMAN; ITALY; PREVALENCE; PRIORITY JOURNAL; RESPIRATORY TRACT INFECTION;

COMMUNITY-ACQUIRED INFECTIONS; DRUG RESISTANCE, BACTERIAL; HAEMOPHILUS INFECTIONS; HUMANS; ITALY; MICROBIAL SENSITIVITY TESTS; PNEUMOCOCCAL INFECTIONS; PREVALENCE; RESPIRATORY TRACT INFECTIONS; SENTINEL SURVEILLANCE;

EID: 20744445551     PISSN: 09248579     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ijantimicag.2005.02.017     Document Type: Article

References (21)

1. T.M. File Jr. Lower respiratory tract infections Infect Dis Clin North Am 18 2004 993 1016
2. A. Marchese, S. Mannelli, E. Tonoli, F. Gorlero, M. Toni, and G.C. Schito Prevalence of antimicrobial resistance in Streptococcus pneumoniae circulating in Italy: results of the Italian Epidemiological Observatory Survey (1997-1999) Microb Drug Resist 7 2001 277 287
3. G. Nicoletti, G. Blandino, R. Musumeci, G. Aleo, A. Speciale, and F. Caccamo Survey on susceptibility of Haemophilus influenzae and Haemophilus parainfluenzae to commonly used antibiotics. Third year results G Ital Microbiol Med Odontoiatrica Clin IV 2000 31 42
4. D. Felmingham, R.N. Grüneberg The Alexander Project Group A multicentre collaborative study of the antimicrobial susceptibility of community-acquired, lower respiratory tract pathogens 1992-1993: The Alexander Project J Antimicrob Chemother 38 Suppl. A 1996 1 57
5. D. Hoban, and D. Felmingham The PROTEKT surveillance study: antimicrobial susceptibility of Haemophilus influenzae and Moraxella catarrhalis from community-acquired respiratory tract infections J Antimicrob Chemother 50 Suppl. S1 2002 49 59
6. G. Nicoletti, A. Speciale, A. Vizzini, L. La Ferrera, G. Blandino, and F. Caccamo Analisi del terzo anno di monitoraggio delle resistenze agli antibiotici in Moraxella catarrhalis G Ital Microbiol Med Odontoiatrica Clin IV 2000 43 50
7. G. Blandino, A. Marchese, and F. Ardito Antimicrobial susceptibility profiles of Pseudomonas aeruginosa and Staphylococcus aureus isolated in Italy from patients with hospital-acquired infections Int J Antimicrob Agents 24 2004 515 518
8. P.R. Murray, E.J. Baron, J.H. Jorgensen, M.A. Pfaller, and R.H. Yolken Manual of clinical microbiology 8th ed. 2003 American Society for Microbiology Washington, DC
9. National Committee for Clinical Laboratory Standards Methods for dilution antimicrobial susceptibility tests for bacteria that grow aerobically. Approved Standard 6th ed. 2004 NCCLS Wayne, PA (M7-A6 and M100-S14)
10. RC. Moellering Jr. The continuing challenge of lower respiratory tract infections Clin Infect Dis 38 Suppl. 4 2004 S319 S321
11. M.R. Jacobs, and C.E. Johnson Macrolide resistance: an increasing concern for treatment failure in children Pediatr Infect Dis J 22 Suppl. 8 2003 131 138
12. M. Rzeszutek, A. Wierzbowski, D.J. Hoban, J. Conly, W. Bishai, and G.G. Zhanel A review of clinical failures associated with macrolide-resistant Streptococcus pneumoniae Int J Antimicrob Agents 24 2004 95 104
13. C.D. Rothermel Penicillin and macrolide resistance in pneumococcal pneumonia: does in vitro resistance affect clinical outcomes? Clin Infect Dis 15 Suppl. 4 2004 346 349
14. K.P. Klugman, D.E. Low, J. Metlay, J.C. Pechere, and K. Weiss Community-acquired pneumonia: new management strategies, evolving pathogens and antimicrobial susceptibilities Int J Antimicrob Agents 24 2004 411 422
15. G.C. Schito, and A. Marchese The impact of antibiotic resistance in the management of lower respiratory tract infections Eur Respir Mon 28 2004 131 145
16. P.L. Ho, T.L. Que, and S.S. Chiu Fluoroquinolone and other antimicrobial resistance in invasive pneumococci, Hong Kong, 1995-2001 Emerg Infect Dis 10 2004 1250 1257
17. J.D. Heffelfinger, S.F. Dowell, and J.H. Jorgensen Management of community-acquired pneumonia in the era of pneumococcal resistance: a report from the Drug-Resistant Streptococcus pneumoniae Therapeutic Working Group Arch Intern Med 160 2000 1399 1408
18. A. Marchese, E. Tonoli, E.A. Debbia, and G.C. Schito Macrolide resistance mechanisms and expression of phenotypes among Streptococcus pneumoniae circulating in Italy J Antimicrob Chemother 44 1999 461 464
19. D.K. Chen, A. McGeer, J.C. de Azavedo, and D.E. Low Decreased susceptibility of Streptococcus pneumoniae to fluoroquinolones in Canada N Engl J Med 341 1999 233 239
20. J. Linares, A.G. de la Campa, and R. Pallares Fluoroquinolone resistance in Streptococcus pneumoniae N Engl J Med 341 1999 1546 1547
21. J. Nazir, C. Urban, and N. Mariano Haemophilus influenzae in a long-term-care facility: nucleotide sequence characterization of alterations in the genes encoding DNA gyrase and DNA topoisomerase IV Antimicrob Agents Chemother 48 2004 3570 3572